Neurovations
Neurovations, founded in 1992 and based in Napa, CA, offers comprehensive patient care services including chronic pain management, laboratory services, and TMS therapy. The company also engages in clinical research, medical innovation, and hosts educational conferences on pain management.
Neurovations Company History
Neurovations was founded in 1992 and is based in Napa, California. Over the years, the company has evolved to become a multifaceted institution with a strong presence in patient care, medical research, and education. The company's history is marked by significant growth and contributions to fields such as chronic pain management, neuroscience, and medical innovation.
Neurovations Services
Neurovations offers a comprehensive suite of patient care services. These include chronic pain management, laboratory services, and a surgery center. They also provide transcranial magnetic stimulation (TMS) therapy specifically for treating Major Depressive Disorder (MDD). Their Napa Surgery Center is a state-of-the-art facility designed to cater to various surgical needs. Additionally, Neurovations operates N3 Laboratories, which focuses on safer prescribing practices.
Neurovations Educational Initiatives
Neurovations is deeply involved in education and research through its Neurovations Education platform. The company offers webinars, bioskills labs, and clinical research programs aimed at advancing knowledge in pain and neuroscience. They also organize the Napa Pain Conference and the Kaua'i Pain Conference, which serve as significant platforms for sharing the latest research and developments in pain management.
Neurovations Awards and Recognition
In 2022, Neurovations received the Best of Napa Award for Outstanding COVID Testing Services. They were also awarded a $6.9 million grant by the NIH HEAL Initiative for an educational pain research program. These acknowledgments affirm Neurovations' commitment to excellence in healthcare and research.
Neurovations Research and Innovation
Neurovations is a key player in medical device and pharmaceutical innovation. The company participates in drug trials aimed at preventing Alzheimer's disease and operates programs such as the Cancer Pain Consortium to improve cancer-related pain management. Their research efforts are further supported by grants and a commitment to diversity, equity, and inclusion in both their workforce and patient care.